[Assessment of the treatment of glucocorticoid-induced osteoporosis].

Shogo Asano, Atsushi Suzuki

Research output: Contribution to journalReview articlepeer-review

1 Citation (Scopus)


Glucocorticoid-induced osteoporosis (GIOP) is known as a serious adverse side effect during long-term glucocorticoid treatment. Several clinical guidelines are available to whom and how we should start to treat GIOP. However, the assessment of the treatment of GIOP is still controversial. Accumulating evidences suggest us that both bone mineral density and bone turn over markers could reflect the effect of some pharmacological agents on bone metabolism. However, further studies would be required for precise assessment of the efficacy of drugs on fracture prevention in GIOP.

Original languageEnglish
Pages (from-to)401-408
Number of pages8
JournalUnknown Journal
Issue number3
Publication statusPublished - 03-2013

All Science Journal Classification (ASJC) codes

  • General Medicine


Dive into the research topics of '[Assessment of the treatment of glucocorticoid-induced osteoporosis].'. Together they form a unique fingerprint.

Cite this